S4.3-39. Brownrigg JRW, de Lusignan S, McGovern A, et al. Peripheral neu- ropathy and the risk of cardiovascular events in type 2 diabetes mel- litus. Heart. 2014;100:1837 43. S4.3-40. Ogren M, Hedblad B, Engstr m G, et al. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year- old men with diabetes. Results from the population study Men born in 1914 from Malm , Sweden. Eur J Vasc Endovasc Surg. 2005;29:182 9. S4.3-41. Pang X-H, Han J, Ye W-L, et al. Lower extremity peripheral arterial disease is an independent predictor of coronary heart disease and stroke risks in patients with type 2 diabetes mellitus in China. Int J Endocrinol. 2017;2017:9620513. S4.3-42. Waheed S, Pollack S, Roth M, et al. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical out- comes with or without statin therapy: The St Francis Heart Study. Atherosclerosis. 2016;255:193 9. 4.4. High Blood Pressure or Hypertension S4.4-1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13 115. CLINICAL STATEMENTS AND GUIDELINES S4.4-2. Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878 84. S4.4-3. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213 20. S4.4-4. Whelton PK, Kumanyika SK, Cook NR, et al. Efficacy of nonphar- macologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. Am J Clin Nutr. 1997;65:652S 60S. S4.4-5. 